Stockscreener 앱 받기
73.54
0.99%
-0.72
전일 마감가:
$74.26
열려 있는:
$74.05
하루 거래량:
9,616
Relative Volume:
0.01
시가총액:
$3.69B
수익:
$379.25M
순이익/손실:
$-77.34M
주가수익비율:
-45.61
EPS:
-1.6122
순현금흐름:
$-27.87M
1주 성능:
-2.39%
1개월 성능:
+2.38%
6개월 성능:
+56.23%
1년 성능:
+88.57%
1일 변동 폭
$73.50
$74.05
1주일 범위
$72.90
$75.56
52주 변동 폭
$36.88
$78.09
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
명칭
Mirum Pharmaceuticals Inc
전화
650-667-4085
주소
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
MIRM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
73.54 | 3.70B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.99 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.20 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.86 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
718.13 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
330.98 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-11 | 재개 | Stifel | Buy |
| 2025-05-19 | 재개 | H.C. Wainwright | Buy |
| 2024-04-17 | 개시 | Stifel | Buy |
| 2023-12-18 | 재확인 | H.C. Wainwright | Buy |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-11-13 | 개시 | Morgan Stanley | Overweight |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-17 | 재개 | Evercore ISI | Outperform |
| 2023-09-20 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-01 | 개시 | Citigroup | Buy |
| 2021-09-20 | 개시 | JP Morgan | Overweight |
| 2020-08-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | 개시 | H.C. Wainwright | Buy |
| 2020-07-31 | 개시 | Piper Sandler | Overweight |
| 2020-06-25 | 개시 | Robert W. Baird | Outperform |
| 2019-08-12 | 개시 | Citigroup | Buy |
| 2019-08-12 | 개시 | Evercore ISI | Outperform |
| 2019-08-12 | 개시 | Guggenheim | Buy |
| 2019-08-12 | 개시 | ROTH Capital | Buy |
| 2019-08-12 | 개시 | Raymond James | Outperform |
모두보기
Mirum Pharmaceuticals Inc 주식(MIRM)의 최신 뉴스
Mirum stock is a new Buy at TD Cowen (MIRM:NASDAQ) - Seeking Alpha
TD Cowen initiates coverage on Mirum Pharmaceuticals stock with Buy rating - Investing.com
CRMD vs. MIRM: Which Specialized Biotech Stock is the Better Pick? - sharewise.com
Contravisory Investment Management Inc. Acquires Shares of 5,307 Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Loss-Making Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Expected To Breakeven In The Medium-Term - Yahoo
Atle Fund Management AB Grows Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
12,200 Shares in Mirum Pharmaceuticals, Inc. $MIRM Bought by Strs Ohio - MarketBeat
Gainers Report: What are Mirum Pharmaceuticals Inc.’s earnings expectationsJuly 2025 Trade Ideas & Safe Entry Momentum Stock Tips - خودرو بانک
Earnings Recap: Should I hold or sell Mirum Pharmaceuticals Inc nowPortfolio Update Summary & Fast Momentum Stock Entry Tips - khodrobank.com
Bond Watch: What is Mirum Pharmaceuticals Inc. s debt to equity ratioMarket Growth Summary & Pattern Based Trade Signal System - khodrobank.com
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives $74.44 Consensus Target Price from Brokerages - MarketBeat
Investment Recap: Is Mirum Pharmaceuticals Inc impacted by rising ratesProduct Launch & Technical Pattern Alert System - خودرو بانک
Retail Trends: Is Springview Holdings Ltd showing insider buyingTrade Entry Report & Expert-Curated Trade Recommendations - خودرو بانک
Mirum Pharmaceuticals, Inc. $MIRM Shares Sold by Millennium Management LLC - MarketBeat
Risk Report: Will Mirum Pharmaceuticals Inc benefit from AI trends2025 Market Overview & Precise Swing Trade Alerts - خودرو بانک
Citizens JMP Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $81 - 富途牛牛
H.C. Wainwright Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $80 - 富途牛牛
Citizens JMP reiterates Market Outperform rating on Mirum Pharmaceuticals stock - Investing.com Canada
Mirum Pharmaceuticals, Inc. $MIRM Shares Bought by Rhumbline Advisers - Defense World
JPMorgan Chase & Co. Issues Positive Forecast for Mirum Pharmaceuticals (NASDAQ:MIRM) Stock Price - MarketBeat
Activity Recap: Is Mirum Pharmaceuticals Inc impacted by rising ratesJuly 2025 Closing Moves & Consistent Return Investment Signals - خودرو بانک
Trade Report: Can Mirum Pharmaceuticals Inc. deliver consistent dividendsMarket Volume Summary & Free Community Consensus Stock Picks - خودرو بانک
Mirum Pharmaceuticals, Inc. $MIRM Holdings Increased by Woodline Partners LP - MarketBeat
Mirum Pharmaceuticals (NASDAQ:MIRM) Reaches New 1-Year HighTime to Buy? - MarketBeat
Mirum Pharmaceuticals Announces Enrollment Completion in the Phase 2b VISTAS Study - Investing News Network
Mirum Pharma director Brege sells $1.26m in shares - Investing.com India
Mirum Pharma director Brege sells $1.26m in shares By Investing.com - Investing.com Canada
J.P. Morgan Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Raises Target Price to $77 - 富途牛牛
Adage Capital Partners GP L.L.C. Purchases 195,000 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Saira Ramasastry, Mirum director, sells $1.3m in shares By Investing.com - Investing.com Canada
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Mirum Pharmaceuticals (NASDAQ:MIRM) Sets New 52-Week HighHere's Why - MarketBeat
Eventide Asset Management LLC Sells 79,938 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals at Morgan Stanley Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Mirum Pharmaceuticals announces enrollment completion in the phase 2b Vistas study - MarketScreener
Published on: 2025-09-08 12:42:47 - beatles.ru
Northern Trust Corp Decreases Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Multi factor analysis applied to Mirum Pharmaceuticals Inc.Weekly Investment Report & Stock Portfolio Risk Management - Newser
Is Mirum Pharmaceuticals Inc. stock overvalued or fairly priced2025 Geopolitical Influence & Short-Term High Return Ideas - خودرو بانک
PDT Partners LLC Has $6.19 Million Stock Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Is Mirum Pharmaceuticals Inc. forming bullish engulfing patternsEarnings Trend Report & Safe Entry Trade Signal Reports - خودرو بانک
Can Mirum Pharmaceuticals Inc. reach resistance levels soon2025 EndofYear Setup & Fast Gain Swing Alerts - خودرو بانک
Real time scanner hits for Mirum Pharmaceuticals Inc. explainedBond Market & AI Driven Stock Movement Reports - Newser
Sentiment analysis tools applied to Mirum Pharmaceuticals Inc.2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Is Mirum Pharmaceuticals Inc. forming a reversal patternPortfolio Growth Summary & Weekly Top Gainers Trade List - Newser
Published on: 2025-09-05 14:03:50 - Newser
Signal strength of Mirum Pharmaceuticals Inc. stock in tech scannersQuarterly Risk Review & Safe Capital Growth Stock Tips - Newser
Chart overlay techniques for tracking Mirum Pharmaceuticals Inc.Earnings Performance Report & Capital Efficiency Focused Ideas - Newser
Rafferty Asset Management LLC Raises Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Will Mirum Pharmaceuticals Inc. stock recover after recent dropMarket Movement Recap & Detailed Earnings Play Alerts - Newser
Mirum Pharmaceuticals Inc (MIRM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.20%
0.35%
자본화:
|
볼륨(24시간):